People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...

Watchdog bans host of ads for prescription-only weight-loss medications - The Advertising Standards Authority said the ...

This week's exercise is a perfect addition for someone on a GLP-1 prescription, because it addresses another element of ...

It is illegal to advertise prescription-only weight loss drugs and Ms Collins' was one of nine adverts banned in a crackdown ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage ...

BRITS using the fat jab Mounjaro could be at risk of deadly organ failure due to a common mistake, an expert has warned.